| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.600 | None | 0.983 | 6 | 0 | 1993 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.600 | None | 0.991 | 5 | 0 | 1996 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.400 | None | 0.982 | 4 | 0 | 1994 | 2020 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
phenotype | 0.400 | None | 0.989 | 4 | 0 | 1993 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.400 | None | 0.976 | 3 | 0 | 1994 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.400 | None | 0.973 | 3 | 0 | 1988 | 2020 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
phenotype | 0.400 | None | 0.960 | 2 | 0 | 1993 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.400 | None | 0.980 | 2 | 0 | 1990 | 2020 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
phenotype | 0.400 | None | 0.983 | 2 | 0 | 2007 | 2020 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.400 | None | 0.989 | 2 | 0 | 2000 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.400 | None | 0.995 | 2 | 0 | 2000 | 2020 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
phenotype | 0.400 | None | 0.962 | 2 | 0 | 1992 | 2020 | ||||||||
|
snail family transcriptional repressor 1 | 0.474 | 0.808 | 0.22 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 2007 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 0.968 | 2 | 0 | 1998 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.996 | 2 | 0 | 2001 | 2020 | ||||||||
|
N-myc downstream regulated 1 | 0.488 | 0.731 | 1.1E-02 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 2003 | 2020 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
phenotype | 0.400 | None | 0.993 | 2 | 0 | 2003 | 2020 | |||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.400 | None | 0.972 | 2 | 0 | 1995 | 2020 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
phenotype | 0.400 | None | 0.940 | 1 | 0 | 1989 | 2020 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.400 | None | 0.989 | 1 | 0 | 1996 | 2020 | ||||||||
|
MNX1 antisense RNA 1 (head to head) | 0.615 | 0.346 |
|
phenotype | 0.360 | None | 1.000 | 1 | 0 | 2017 | 2020 | |||||||||
|
ERCC excision repair 4, endonuclease catalytic subunit | 0.468 | 0.846 | 1.4E-12 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 1 | 0 | 1992 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.400 | None | 0.978 | 1 | 0 | 1992 | 2020 | ||||||||
|
lymphoid enhancer binding factor 1 | 0.486 | 0.769 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2013 | 2020 |